GKOS - Glaukos Corporation

NYSE - NYSE Delayed Price. Currency in USD
26.45
-0.62 (-2.29%)
At close: 4:02PM EST
Stock chart is not supported by your current browser
Previous Close27.07
Open27.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range26.44 - 27.14
52 Week Range26.44 - 52.49
Volume903,594
Avg. Volume762,250
Market Cap914.25M
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)-0.04
Earnings DateMay 4, 2017 - May 5, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est43.88
Trade prices are not sourced from all markets
  • Capital Cube2 days ago

    ETFs with exposure to Glaukos Corp. : November 16, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Glaukos Corp. Here are 5 ETFs with the largest exposure to GKOS-US. Comparing the performance and risk of Glaukos Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Thomson Reuters StreetEvents8 days ago

    Edited Transcript of GKOS earnings conference call or presentation 7-Nov-17 9:30pm GMT

    Q3 2017 Glaukos Corp Earnings Call

  • See what the IHS Markit Score report has to say about Glaukos Corp.
    Markit8 days ago

    See what the IHS Markit Score report has to say about Glaukos Corp.

    Short interest is high for GKOS with between 15 and 20% of shares on loan. This means that investors who seek to profit from falling equity prices are currently targeting GKOS. The net inflows of $2.36 billion over the last one-month into ETFs that hold GKOS are not among the highest of the last year and have been slowing.

  • Associated Press11 days ago

    Glaukos beats Street 3Q forecasts

    The San Clemente, California-based company said it had profit of 4 cents per share. The results topped Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research ...

  • Is This Why Glaukos Corp. Is Tumbling Today?
    Motley Fool11 days ago

    Is This Why Glaukos Corp. Is Tumbling Today?

    Shares fall by double digits without any news. What's going on?

  • Capital Cube18 days ago

    ETFs with exposure to Glaukos Corp. : October 31, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Glaukos Corp. Here are 5 ETFs with the largest exposure to GKOS-US. Comparing the performance and risk of Glaukos Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Business Wire18 days ago

    Glaukos Announces Participation in Stifel 2017 Healthcare Conference

    Glaukos Corporation , an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, today announced that its management is scheduled to participate in the Stifel 2017 Healthcare Conference on Tuesday, November 14, 2017, at 10:15 a.m.

  • Glaukos Corp. breached its 50 day moving average in a Bullish Manner : GKOS-US : October 30, 2017
    Capital Cube19 days ago

    Glaukos Corp. breached its 50 day moving average in a Bullish Manner : GKOS-US : October 30, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Glaukos Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish 50 ... Read more (Read more...)

  • Business Wire25 days ago

    Glaukos Corporation to Release Third Quarter 2017 Financial Results after Market Close on November 7

    Glaukos Corporation , an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, plans to release third quarter 2017 financial results after the market close on Tuesday, November 7, 2017.

  • Capital Cubelast month

    ETFs with exposure to Glaukos Corp. : October 16, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Glaukos Corp. Here are 5 ETFs with the largest exposure to GKOS-US. Comparing the performance and risk of Glaukos Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • See what the IHS Markit Score report has to say about Glaukos Corp.
    Markitlast month

    See what the IHS Markit Score report has to say about Glaukos Corp.

    Short interest is moderately high for GKOS with between 10 and 15% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last month, ETFs holding GKOS are favorable, with net inflows of $2.06 billion.

  • Business Wirelast month

    Glaukos iStent® Products to be Showcased at 2017 European Society of Cataract and Refractive Surgery

    Glaukos Corporation , an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, announced today that various Key Opinion Leader presentations and electronic posters will feature its iStent® Trabecular Micro-Bypass and iStent inject® Trabecular Micro-Bypass products at the upcoming ...

  • Why Glaukos Corp. Stock Sank 12.8% in September
    Motley Foollast month

    Why Glaukos Corp. Stock Sank 12.8% in September

    Management poured cold water on its financial projections for 2017, causes shares to take a step back.

  • Weakness Seen in Glaukos (GKOS) Estimates: Should You Stay Away?
    Zackslast month

    Weakness Seen in Glaukos (GKOS) Estimates: Should You Stay Away?

    Glaukos (GKOS) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.

  • Should You Be Holding Glaukos Corporation (GKOS) Right Now?
    Simply Wall St.2 months ago

    Should You Be Holding Glaukos Corporation (GKOS) Right Now?

    If you are looking to invest in Glaukos Corporation’s (NYSE:GKOS), or currently own the stock, then you need to understand its beta in order to understand how it can affectRead More...

  • Capital Cube2 months ago

    ETFs with exposure to Glaukos Corp. : October 2, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Glaukos Corp. Here are 5 ETFs with the largest exposure to GKOS-US. Comparing the performance and risk of Glaukos Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Glaukos Corp. :GKOS-US: Earnings Analysis: Q2, 2017 By the Numbers : September 29, 2017
    Capital Cube2 months ago

    Glaukos Corp. :GKOS-US: Earnings Analysis: Q2, 2017 By the Numbers : September 29, 2017

    Categories: Yahoo FinanceGet free summary analysis Glaukos Corp. reports financial results for the quarter ended June 30, 2017. Highlights Summary numbers: Revenues of USD 41.29 million, Net Earnings of USD -3.30 million. Gross margins widened from 84.74% to 86.62% compared to the same period last year, operating (EBITDA) margins now 5.99% from 11.53%. Change in operating cash ... Read more (Read more...)

  • Glaukos Corp. breached its 50 day moving average in a Bearish Manner : GKOS-US : September 15, 2017
    Capital Cube2 months ago

    Glaukos Corp. breached its 50 day moving average in a Bearish Manner : GKOS-US : September 15, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Glaukos Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish 50 ... Read more (Read more...)

  • Here's Why Glaukos Corp. Stock Is Stumbling Today
    Motley Fool2 months ago

    Here's Why Glaukos Corp. Stock Is Stumbling Today

    Investors aren't too pleased with recent revisions to this year's sales expectations.

  • Is It Too Late To Buy Glaukos Corporation (GKOS)?
    Simply Wall St.2 months ago

    Is It Too Late To Buy Glaukos Corporation (GKOS)?

    Glaukos Corporation (NYSE:GKOS), a healthcare equipment and services company based in United States, View our latest analysis for Glaukos What’s the opportunity in GKOS? According to my relative valuation model,Read More...

  • Business Wire2 months ago

    Glaukos to Outline Growth Strategy at Investor Day

    Glaukos Corporation , an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, will provide an overview of its growth strategy and market opportunity, update progress of its innovative pipeline products and revise 2017 net sales guidance during its Investor Day meeting today in ...

  • See what the IHS Markit Score report has to say about Glaukos Corp.
    Markit2 months ago

    See what the IHS Markit Score report has to say about Glaukos Corp.

    Short interest is moderately high for GKOS with between 10 and 15% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last month, ETFs holding GKOS are favorable, with net inflows of $2.47 billion.

  • See what the IHS Markit Score report has to say about Glaukos Corp.
    Markit2 months ago

    See what the IHS Markit Score report has to say about Glaukos Corp.

    Short interest is moderately high for GKOS with between 10 and 15% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last month, ETFs holding GKOS are favorable, with net inflows of $2.23 billion.